Exhibit 99.1

 

JOINT FILING AGREEMENT

PURSUANT TO RULE 13D-1(k)(1)

 

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is accurate.

 

 

  John Hathaway  
   
  Signature: /s/ John Hathaway  
  Name/Title:

John Hathaway
  Date: 02/10/2025  

 

  SkinJect Partners LLC  
   
  Signature: /s/ John Hathaway  
  Name/Title:

John Hathaway, Managing Director

  
  Date: 02/10/2025  

 

 

 

 

 

Medicus Pharma (PK) (USOTC:MDPLF)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Medicus Pharma (PK) Charts.
Medicus Pharma (PK) (USOTC:MDPLF)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Medicus Pharma (PK) Charts.